Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be i...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-12-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article |
_version_ | 1818523335449903104 |
---|---|
author | William T. Hu J. Christina Howell Tugba Ozturk Karima Benameur Leda C. Bassit Richard Ramonell Kevin S. Cashman Shama Pirmohammed John D. Roback Vincent C. Marconi Irene Yang Valerie V. Mac Daniel Smith Ignacio Sanz Whitney Wharton F. Eun-Hyung Lee Raymond F. Schinazi |
author_facet | William T. Hu J. Christina Howell Tugba Ozturk Karima Benameur Leda C. Bassit Richard Ramonell Kevin S. Cashman Shama Pirmohammed John D. Roback Vincent C. Marconi Irene Yang Valerie V. Mac Daniel Smith Ignacio Sanz Whitney Wharton F. Eun-Hyung Lee Raymond F. Schinazi |
author_sort | William T. Hu |
collection | DOAJ |
description | Among patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19. |
first_indexed | 2024-12-11T05:43:43Z |
format | Article |
id | doaj.art-e763d22d1815415ea1ca5c5f3ff79d91 |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-12-11T05:43:43Z |
publishDate | 2020-12-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-e763d22d1815415ea1ca5c5f3ff79d912022-12-22T01:19:03ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592020-12-0126122974297810.3201/eid2612.203334Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020William T. HuJ. Christina HowellTugba OzturkKarima BenameurLeda C. BassitRichard RamonellKevin S. CashmanShama PirmohammedJohn D. RobackVincent C. MarconiIrene YangValerie V. MacDaniel SmithIgnacio SanzWhitney WhartonF. Eun-Hyung LeeRaymond F. SchinaziAmong patients with coronavirus disease (COVID-19), IgM levels increased early after symptom onset for those with mild and severe disease, but IgG levels increased early only in those with severe disease. A similar pattern was observed in a separate serosurveillance cohort. Mild COVID-19 should be investigated separately from severe COVID-19.https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article2019 novel coronavirus diseasecoronavirus diseaseCOVID-19severe acute respiratory syndrome coronavirus 2SARS-CoV-2viruses |
spellingShingle | William T. Hu J. Christina Howell Tugba Ozturk Karima Benameur Leda C. Bassit Richard Ramonell Kevin S. Cashman Shama Pirmohammed John D. Roback Vincent C. Marconi Irene Yang Valerie V. Mac Daniel Smith Ignacio Sanz Whitney Wharton F. Eun-Hyung Lee Raymond F. Schinazi Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 Emerging Infectious Diseases 2019 novel coronavirus disease coronavirus disease COVID-19 severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 viruses |
title | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 |
title_full | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 |
title_fullStr | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 |
title_full_unstemmed | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 |
title_short | Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020 |
title_sort | antibody profiles according to mild or severe sars cov 2 infection atlanta georgia usa 2020 |
topic | 2019 novel coronavirus disease coronavirus disease COVID-19 severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 viruses |
url | https://wwwnc.cdc.gov/eid/article/26/12/20-3334_article |
work_keys_str_mv | AT williamthu antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT jchristinahowell antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT tugbaozturk antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT karimabenameur antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT ledacbassit antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT richardramonell antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT kevinscashman antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT shamapirmohammed antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT johndroback antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT vincentcmarconi antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT ireneyang antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT valerievmac antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT danielsmith antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT ignaciosanz antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT whitneywharton antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT feunhyunglee antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 AT raymondfschinazi antibodyprofilesaccordingtomildorseveresarscov2infectionatlantageorgiausa2020 |